GlassScriptPhysician profile
Uyen H Ta
NPI 1184634198
$1,190.46
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $765 · 2020: $410 · 2021: $15.39.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $679.12 | 2019-2021 | |
| Abbvie INC. | $130.35 | 2020 | |
| Allergan, INC. | $48.47 | 2019-2020 | |
| Lupin INC. | $44.82 | 2020 | |
| Avion Pharmaceuticals | $44.70 | 2019-2020 | |
| Coopersurgical, INC. | $38.65 | 2020 | |
| Merck Sharp & Dohme LLC | $33.07 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $32.51 | 2020 | |
| Pfizer INC. | $25.09 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.03 | 2019 | |
| Duchesnay USA Incorporated | $18.43 | 2019 | |
| Therapeuticsmd, INC. | $18.37 | 2020 | |
| Vertical Pharmaceuticals, LLC | $18.18 | 2019 | |
| Acessa Health INC. | $15.56 | 2019 | |
| Ascend Therapeutics US, LLC | $12.80 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $11.31 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Uyen Ta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.